KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Issued
Ratios

Bionano Genomics (BNGO) Long-Term Debt Issuances (2018 - 2023)

Historic Long-Term Debt Issuances for Bionano Genomics (BNGO) over the last 4 years, with Q4 2023 value amounting to $80.0 million.

  • Bionano Genomics' Long-Term Debt Issuances changed N/A to $80.0 million in Q4 2023 from the same period last year, while for Sep 2025 it was $80.0 million, marking a year-over-year decrease of 94.23%. This contributed to the annual value of $18.0 million for FY2024, which is 7750.0% down from last year.
  • As of Q4 2023, Bionano Genomics' Long-Term Debt Issuances stood at $80.0 million.
  • Bionano Genomics' Long-Term Debt Issuances' 5-year high stood at $80.0 million during Q4 2023, with a 5-year trough of -$38000.0 in Q3 2019.
  • For the 3-year period, Bionano Genomics' Long-Term Debt Issuances averaged around $20.0 million, with its median value being $761000.0 (2020).
  • Per our database at Business Quant, Bionano Genomics' Long-Term Debt Issuances plummeted by 10036.39% in 2019 and then soared by 230094.86% in 2020.
  • Quarter analysis of 3 years shows Bionano Genomics' Long-Term Debt Issuances stood at -$34576.0 in 2019, then skyrocketed by 2300.95% to $761000.0 in 2020, then surged by 10412.48% to $80.0 million in 2023.
  • Its Long-Term Debt Issuances stands at $80.0 million for Q4 2023, versus $761000.0 for Q4 2020 and -$34576.0 for Q4 2019.